Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells.
Altered lipoprotein lipase regulation associated with diabetes leading to the development of hypertriglyceridemia might be attributed to possible changes in content and the fine structure of heparan sulfate and its associated lipoprotein lipase. Adipocyte cell surface is the primary site of synthesis of lipoprotein lipase and the enzyme is bound to cell surface heparan sulfate proteoglycans via heparan sulfate side chains. In this study, the effect of diabetes on the production of adipocyte heparan sulfate and its sulfation (especially N-sulfation) were examined. Mouse 3T3-L1 adipocytes were exposed to high glucose (25 mM) and low glucose (5.55 mM) in the medium and cell-associated heparan sulfate was isolated and characterized. A significant decrease in total content of heparan sulfate was observed in adipocytes cultured under high glucose as compared to low glucose conditions. The degree of N-sulfation was-assessed through oligosaccharide mapping of heparan sulfate after chemical cleavages involving low pH (1.5) nitrous acid and hydrazinolysis/high pH (4.0) nitrous acid treatments; N-sulfation was found to be comparable between the adipocyte heparan sulfates produced under these glucose conditions. The activity and message levels for N-deacetylase/N-sulfotransferase, the enzyme responsible for N-sulfation in the biosynthesis of heparan sulfate, did not vary in adipocytes whether they were exposed to low or high glucose. While most cells or tissues in diabetic situations produce heparan sulfate with low-charge density concomitant with a decrease in N-sulfation, adipocyte cell system is an exception in this regard. Heparan sulfate from adipocytes cultured in low glucose conditions binds to lipoprotein lipase by the same order of magnitude as that derived from high glucose conditions. It is apparent that adipocytes cultured under high glucose conditions produce diminished levels of heparan sulfate (without significant changes in N-sulfation). In conclusion, it is possible that the reduction in heparan sulfate in diabetes could contribute to the decreased levels of heparan sulfate associated lipoprotein lipase, leading to diabetic hypertriglyceridemia.
Parthasarathy
N
N
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1040, USA.
Gotow
L F
LF
Bottoms
J D
JD
Obunike
J C
JC
Naggi
A
A
Casu
B
B
Goldberg
I J
IJ
Wagner
W D
WD
D016475:3T3 Cells; D017667:Adipocytes / Q000378:metabolism*; D000581:Amidohydrolases / Q000378:metabolism; D000818:Animals; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D006497:Heparan Sulfate / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism*; D008071:Lipoprotein Lipase / Q000378:metabolism; D051379:Mice; D008970:Molecular Weight; D015238:Sulfotransferases / Q000378:metabolism
D000581:Amidohydrolases; D005947:Glucose; D006497:Heparan Sulfate; D008071:Lipoprotein Lipase; D015238:Sulfotransferases; C021350:heparitin sulfotransferase